Novo Nordisk Childhood Obesity Prevention Initiative
From Bagsværd, Denmark, on October 8, 2024, Novo Nordisk (NVO) announced a new global initiative to prevent obesity in children. The Childhood Obesity Prevention Initiative aims to accelerate the prevention of childhood obesity in disadvantaged urban communities globally.
Together with partners, which include city governments, academic institutions, and non-profit organizations, the initiative will support six cities in designing, implementing, and evaluating tailored solutions focused on physical activity and healthy eating.
The initiative is founded on a robust evidence-based framework to measure and evaluate the impact of the interventions. In the project, changes in health behavior and well-being, including health-related quality of life and body mass index (BMI) will be measured in children aged 6-13 at baseline and with follow-ups one and two years after the intervention, respectively.
The initiative has a controlled study design and will include a target population receiving the intervention compared to a control group in each city. The aim is to collect data from approximately 1,000 children in each group.
From Novo Nordisk
Katrine DiBona, Global Head of Sustainability & Public Affairs at Novo Nordisk said, “Childhood obesity is rising at alarming rates all over the world, putting the health and well-being of this and future generations at risk. With a focus on disadvantaged children’s urban communities, the Childhood Obesity Prevention Initiative will provide important evidence and a unique data-led framework to support city leaders in preventing childhood obesity.
The initiative builds on over a decade of experience in city-based prevention programs through Cities for Better Health. It will be rolled out in an initial set of six cities across Brazil, Canada, France, Japan, South Africa, and Spain.
About Childhood Obesity
In 2022, more than 390 million children aged 5–19 years were affected by overweight worldwide. They include 160 million living with obesity. This puts them at risk of developing early onset of type 2 diabetes and is a strong predictor of adult obesity. Children from lower socioeconomic communities tend to have an increased risk of obesity.
About Childhood Obesity Prevention Initiative
In the project, global partners, Delivery Associates and Behavioral Insight Team (BIT) will support the design and delivery of the interventions and evaluation in collaboration with a coalition of cross-sector local partners such as city governments, academic institutions, and non-profit organizations. After 24 months, the impact is measured through a robust monitoring and evaluation framework.
The learning generated will be used as guidance to city and community leaders worldwide on how to design, implement, measure, and sustain effective interventions.
The initiative is part of Novo Nordisk’s social responsibility efforts to address obesity holistically as a serious chronic disease.
In the project, global partners, Delivery Associates and Behavioural Insights Team will support the design and delivery of the interventions and evaluation in collaboration with a coalition of cross-sector local partners such as city governments, academic institutions, and non-profit organizations. After 24 months, the impact is measured through a robust monitoring and evaluation framework.
The learning generated will be used as a guide to community cities and leaders worldwide on how to design, implement, measure, and sustain effective interventions.
The initiative is part of Novo Nordisk’s social responsibility efforts to address obesity holistically as a serious chronic disease.
About Cities for Better Health
The initiative is part of Cities for Better Health, a global public-private partnership committed to accelerating change in urban health across generations by building impactful local partnerships to drive health promotion and prevention. The partnership, formerly called Cities Changing Diabetes, takes a holistic approach to drive impactful community-based action to promote healthy food consumption and physical activity among children and vulnerable communities. Today, more than 50 cities and 300 partners are collaborating through the program.
Novo Nordisk
Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. The firm aims to drive change to defeat serious chronic diseases built upon its heritage in diabetes. Novo Nordisk said it works pioneering scientific breakthroughs, expanding access to our medicines, and working to prevent and cure disease. Novo Nordisk has around 69,000 people in 80 countries and markets its products in around 170 countries.
Prohost Observations
The reason we posted the Novo Nordisk press release under our free column, News & Comments, is to help as many parents as possible learn about the launch of the company’s global children initiative, which will prevent children from a future full of severe diseases, including diabetes and obesity.
Click here to read more about Novo Nordisk.
News & Comments
October 11, 2024
Novo Nordisk Launches New Initiative To Prevent Childhood Obesity In Disadvantaged Urban Communities
Novo Nordisk Childhood Obesity Prevention Initiative
From Bagsværd, Denmark, on October 8, 2024, Novo Nordisk (NVO) announced a new global initiative to prevent obesity in children. The Childhood Obesity Prevention Initiative aims to accelerate the prevention of childhood obesity in disadvantaged urban communities globally.
Together with partners, which include city governments, academic institutions, and non-profit organizations, the initiative will support six cities in designing, implementing, and evaluating tailored solutions focused on physical activity and healthy eating.
The initiative is founded on a robust evidence-based framework to measure and evaluate the impact of the interventions. In the project, changes in health behavior and well-being, including health-related quality of life and body mass index (BMI) will be measured in children aged 6-13 at baseline and with follow-ups one and two years after the intervention, respectively.
The initiative has a controlled study design and will include a target population receiving the intervention compared to a control group in each city. The aim is to collect data from approximately 1,000 children in each group.
From Novo Nordisk
Katrine DiBona, Global Head of Sustainability & Public Affairs at Novo Nordisk said, “Childhood obesity is rising at alarming rates all over the world, putting the health and well-being of this and future generations at risk. With a focus on disadvantaged children’s urban communities, the Childhood Obesity Prevention Initiative will provide important evidence and a unique data-led framework to support city leaders in preventing childhood obesity.
The initiative builds on over a decade of experience in city-based prevention programs through Cities for Better Health. It will be rolled out in an initial set of six cities across Brazil, Canada, France, Japan, South Africa, and Spain.
About Childhood Obesity
In 2022, more than 390 million children aged 5–19 years were affected by overweight worldwide. They include 160 million living with obesity. This puts them at risk of developing early onset of type 2 diabetes and is a strong predictor of adult obesity. Children from lower socioeconomic communities tend to have an increased risk of obesity.
About Childhood Obesity Prevention Initiative
In the project, global partners, Delivery Associates and Behavioral Insight Team (BIT) will support the design and delivery of the interventions and evaluation in collaboration with a coalition of cross-sector local partners such as city governments, academic institutions, and non-profit organizations. After 24 months, the impact is measured through a robust monitoring and evaluation framework.
The learning generated will be used as guidance to city and community leaders worldwide on how to design, implement, measure, and sustain effective interventions.
The initiative is part of Novo Nordisk’s social responsibility efforts to address obesity holistically as a serious chronic disease.
In the project, global partners, Delivery Associates and Behavioural Insights Team will support the design and delivery of the interventions and evaluation in collaboration with a coalition of cross-sector local partners such as city governments, academic institutions, and non-profit organizations. After 24 months, the impact is measured through a robust monitoring and evaluation framework.
The learning generated will be used as a guide to community cities and leaders worldwide on how to design, implement, measure, and sustain effective interventions.
The initiative is part of Novo Nordisk’s social responsibility efforts to address obesity holistically as a serious chronic disease.
About Cities for Better Health
The initiative is part of Cities for Better Health, a global public-private partnership committed to accelerating change in urban health across generations by building impactful local partnerships to drive health promotion and prevention. The partnership, formerly called Cities Changing Diabetes, takes a holistic approach to drive impactful community-based action to promote healthy food consumption and physical activity among children and vulnerable communities. Today, more than 50 cities and 300 partners are collaborating through the program.
Read More here.
Novo Nordisk
Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. The firm aims to drive change to defeat serious chronic diseases built upon its heritage in diabetes. Novo Nordisk said it works pioneering scientific breakthroughs, expanding access to our medicines, and working to prevent and cure disease. Novo Nordisk has around 69,000 people in 80 countries and markets its products in around 170 countries.
For more information, visit novonordisk.com, Facebook, Instagram, X, LinkedIn and YouTube.
Prohost Observations
The reason we posted the Novo Nordisk press release under our free column, News & Comments, is to help as many parents as possible learn about the launch of the company’s global children initiative, which will prevent children from a future full of severe diseases, including diabetes and obesity.
Click here to read more about Novo Nordisk.
Other Articles